Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (271-280 of 655) with videos related to

Pageof 66
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Topotecan in colorectal cancer: a phase II study of the EORTC early clinical trials groupG J Creemers, J Wanders, T Gamucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)R H Mathijssen, R J van Alphen, J Verweij, et al.
Breast Cancer Research and Treatment|May 1, 1995
Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancerM Bontenbal, A S Planting, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapyR de Wit, M E van der Burg, A van den Gaast, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group studyJ Verweij, I Judson, W Steward, et al.
Seminars in Perinatology|November 29, 2021
Dutch guidelines on care for extremely premature infants: Navigating between personalisation and standardizationE J Verweij, Lien De Proost, Marije Hogeveen, et al.
Interactive Cardiovascular and Thoracic Surgery|July 5, 2012
Serum cortisol concentration with exploratory cut-off values do not predict the effects of hydrocortisone administration in children with low cardiac output after cardiac surgeryE J Verweij, Karin Hogenbirk, Arno A W Roest, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitorJ Verweij, B Lund, J Beijnen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma GroupR Somers, A Santoro, J Verweij, et al.
Molecular and Cellular Probes|October 29, 2003
Real-time PCR for the detection of Giardia lambliaJaco J Verweij, Janke Schinkel, Daphne Laeijendecker, et al.
Pageof 66

Showing results (271-280 of 655) with videos related to

Sort By:
Pageof 66
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Topotecan in colorectal cancer: a phase II study of the EORTC early clinical trials groupG J Creemers, J Wanders, T Gamucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)R H Mathijssen, R J van Alphen, J Verweij, et al.
Breast Cancer Research and Treatment|May 1, 1995
Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancerM Bontenbal, A S Planting, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapyR de Wit, M E van der Burg, A van den Gaast, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group studyJ Verweij, I Judson, W Steward, et al.
Seminars in Perinatology|November 29, 2021
Dutch guidelines on care for extremely premature infants: Navigating between personalisation and standardizationE J Verweij, Lien De Proost, Marije Hogeveen, et al.
Interactive Cardiovascular and Thoracic Surgery|July 5, 2012
Serum cortisol concentration with exploratory cut-off values do not predict the effects of hydrocortisone administration in children with low cardiac output after cardiac surgeryE J Verweij, Karin Hogenbirk, Arno A W Roest, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitorJ Verweij, B Lund, J Beijnen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma GroupR Somers, A Santoro, J Verweij, et al.
Molecular and Cellular Probes|October 29, 2003
Real-time PCR for the detection of Giardia lambliaJaco J Verweij, Janke Schinkel, Daphne Laeijendecker, et al.
Pageof 66